- Home
- CLNN vs ADVB Comparison
CLNN vs ADVB Comparison
Compare CLNN & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- ADVB
- Stock Information
- Founded
- CLNN 2012
- ADVB 2014
- Country
- CLNN United States
- ADVB United States
- Employees
- CLNN N/A
- ADVB N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- ADVB Medical Specialities
- Sector
- CLNN Health Care
- ADVB Health Care
- Exchange
- CLNN Nasdaq
- ADVB Nasdaq
- Market Cap
- CLNN 23.1M
- ADVB 20.8M
- IPO Year
- CLNN N/A
- ADVB 2025
- Fundamental
- Price
- CLNN $3.76
- ADVB $0.64
- Analyst Decision
- CLNN Strong Buy
- ADVB
- Analyst Count
- CLNN 5
- ADVB 0
- Target Price
- CLNN $40.00
- ADVB N/A
- AVG Volume (30 Days)
- CLNN 141.3K
- ADVB 135.8K
- Earning Date
- CLNN 08-06-2025
- ADVB 08-03-2025
- Dividend Yield
- CLNN N/A
- ADVB N/A
- EPS Growth
- CLNN N/A
- ADVB N/A
- EPS
- CLNN N/A
- ADVB N/A
- Revenue
- CLNN $350,000.00
- ADVB N/A
- Revenue This Year
- CLNN N/A
- ADVB N/A
- Revenue Next Year
- CLNN $1,753.57
- ADVB N/A
- P/E Ratio
- CLNN N/A
- ADVB N/A
- Revenue Growth
- CLNN N/A
- ADVB N/A
- 52 Week Low
- CLNN $2.28
- ADVB $0.56
- 52 Week High
- CLNN $7.59
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- CLNN 52.37
- ADVB N/A
- Support Level
- CLNN $4.12
- ADVB N/A
- Resistance Level
- CLNN $4.40
- ADVB N/A
- Average True Range (ATR)
- CLNN 0.26
- ADVB 0.00
- MACD
- CLNN -0.06
- ADVB 0.00
- Stochastic Oscillator
- CLNN 7.89
- ADVB 0.00
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.